About Sance
The company has 130 employees. Sance offers products and services including Cephalosporin Injections and Cephalosporin Tablets and Capsules.
- Employees 130
- SectorsHealthcare
- Email••••••••
- Legal Name Sance Laboratories Pvt. Ltd
- Date of Incorporation 20 Sep, 2001
- Jurisdiction Kottayam, Kerala, India
- Annual Revenue₹64.38 Cr
FY 2025 · +16% YoY
- Net Profit₹4.47 Cr
FY 2025 · 7% margin
- EBITDA₹10.07 Cr
FY 2025 · 16% margin
- Employee Count130
Associated legal entities of Sance
Sance operates through Sance Laboratories Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Sance Laboratories Private Limited CIN U24231KL2001PTC014957 | Active | 20 Sep 2001 | Kottayam, Kerala | ₹64.4 Cr | 118 | 4 | View details |
Products & Services of Sance
Sance offers a comprehensive portfolio of products and services, including Cephalosporin Injections and Cephalosporin Tablets and Capsules.
Dry powder for injections is produced as part of Cephalosporin antibiotic formulations
Tablets and capsules are manufactured in Cephalosporin formulations for various uses
Board of directors of Sance Laboratories Private Limited (Sance)
Sance Laboratories Private Limited is the primary company behind Sance. The board of Sance Laboratories Private Limited currently have 4 directors; the longest-serving is Jatin Joseph, appointed in 2001. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Jatin Joseph DIN 05162520 | Director | 20 Sep 2001 | 25 yrs | Sance Laboratories Private Limited |
| Manoj Joseph DIN 01203664 | Managing Director | 20 Sep 2001 | 25 yrs | Sance Laboratories Private Limited |
| Joseph . Manoj DIN 10236853 | Whole-time director | 07 Jul 2025 | 1 yr 3 mo | Sance Laboratories Private Limited |
| Joby Paul DIN 02672888 | Whole-Time Director | 07 Jul 2025 | 1 yr 3 mo | Sance Laboratories Private Limited |
People of Sance
1 people are tracked at Sance (1 in team); the tracked headcount is 130.
| Name | Role | Group |
|---|---|---|
| Owner | Team |
Complete people profiles for Sance
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Sance
Figures of Sance Laboratories Private Limited, the primary company behind Sance, for FY 2025. Revenue was ₹64.38 Cr (+16% year on year). Net profit was ₹4.47 Cr (7% margin). EBITDA was ₹10.07 Cr (16% margin). Revenue has grown at a compounded annual rate of +961% over three years and +14% over five years.
- ₹64.38 CrRevenue · FY 2025 · +16% YoY
- ₹4.47 CrNet profit · 7% margin
- ₹10.07 CrEBITDA · 16% margin
- ₹3.96 CrPaid-up capital
- 118Employees (provident fund records)
- +961%Revenue CAGR, 3 years
- +14%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Sance Laboratories Private Limited are on its company page.
Detailed financial statements for Sance
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Sance
10 companies that operate in the same segment as Sance (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Sance
Sance has 130 employees.
The primary company behind Sance, Sance Laboratories Private Limited, reported revenue of ₹64.38 Cr for FY 2025, up 16% year on year.
Sance is recognized for its role in manufacturing Cephalosporin antibiotic formulations, with operations established in 2003 in Kerala, India. Various dosage forms, such as injections, tablets, capsules, dry syrups, and sachets, are produced and supplied to over 50 countries across four continents. Accreditations including WHO-GMP and ISO standards are maintained, while contract manufacturing services are provided for pharmaceutical companies. Quality practices are adhered to, ensuring safety and efficacy in production processes. (72 words).
Sance offers Cephalosporin Injections and Cephalosporin Tablets and Capsules.
Sance operates through Sance Laboratories Private Limited.
The legal entities of Sance currently have 4 directors, including Joseph . Manoj, Jatin Joseph, Manoj Joseph and others.